Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION

por Kloka, Jan, Friedrichson, Benjamin, Dauth, Stephanie, Foldenauer, Ann Christina, Bulczak-Schadendorf, Anita, Vehreschild, Maria J. G. T., Matos, Francisco Maio, Riera-Mestre, Antoni, van Asselt, Antoinette D. I., De Robertis, Edoardo, Juskeviciene, Vilma Traskaite, Meybohm, Patrick, Tomescu, Dana, Lacombe, Karine, Stehouwer, Coen D. A., Zacharowski, Kai
Publicado 2022